Clinical Trial Update: A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the combination of Aliskiren, Valsartan, and Hydrochlorothiazide in diabetic hypertensive nonresponders; com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Diabetes | Phase 3 | Status: COMPLETED